Autoimmune diseases, such as rheumatoid arthritis and inflammatory bow
el disease are characterized by chronic inflammatory responses resulti
ng in tissue damage. These diseases have a number of common denominato
rs including: abnormal cytokine expression, aberrant antigen-antibody
complexes, T cell anomalies, and increased numbers of neutrophils and
macrophages. We propose that the interaction between neutrophils and m
acrophages induces a state of chronic inflammation which contributes t
o the disease state. One of the central players in this scenario is my
eloperoxidase (MyPo). This enzyme functions in the 'cytotoxic triad' a
nd is involved in cell killing. Studies done by the present investigat
ors have shown that MyPo, which is released from neutrophils, induces
macrophages to secrete interleukin-1, interferon alpha beta and tumor
necrosis factor alpha. Furthermore, our studies have suggested a major
immunoregulatory role of this enzyme. We propose that the release of
MyPo from neutrophils and subsequent binding to macrophages initiates
a cascade of events which enhance the production of reactive oxygen in
termediates and cytokine expression resulting in the chronic inflammat
ory state associated with autoimmune diseases.